CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO

Introducing the latest benzodiazepine metabolite internal standards from Cerilliant - Norchlordiazepoxide-D5 & N-Desmethylclobazam-13C6.

Refer to N-101 N-088
100 µg/mL in 10% Water in Acetonitrile (v/v)

This internal standard is suited for quantification of norchlordiazepoxide in LC/MS and GC/MS benzodiazepine testing methods for urine drug testing, forensic analysis, and clinical toxicology applications. Norchlordiazepoxide is a major urinary metabolite of the benzodiazepine chlordiazepoxide, indicated for short term treatment of severe anxiety and for the management of acute alcohol withdrawal syndrome. The metabolite, also known as N-desmethylchlordiazepoxide, is pharmacologically active.

N-Desmethylclobazam-8-chloro D-094
100 µg/mL in Acetonitrile

n-Desmethylclobazam-8-chloro isomer-13C6 is a stable-labeled structural isomer of N-Desmethylclobazam, also known as norclobazam. This standard is suitable for quantification of N-Desmethylclobazam levels in urine or other matrices by LC/MS or GC/MS for clinical toxicology, urine drug testing, or forensic analysis applications. Norclobazam is a pharmacologically active biomarker and a major metabolite of clobazam, a benzodiazepine marketed under the brand names Frisium, Urbanol, and Onfi for use as an anxiolytic and anticonvulsant.

Coming soon Cerilliant will offer the following benzodiazepine internal standards:
Phenazepam-D4 (P-093)
Clobazam-13C6 (C-129)

Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.

All New Product Announcements

© 2021 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact